Related Experiment Videos
Current concepts in management of thyroid disease
The Medical Clinics of North America
|January 1, 1970
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Journal of endocrinological investigation·2002
Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
Thyroid : official journal of the American Thyroid Association·2001
CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
Journal of immunology (Baltimore, Md. : 1950)·2000
Sleep Disorders: Management by Alternative Therapies.
The Medical clinics of North America·2026
Sleep Pharmacology: Medications Affecting Sleep and Medications to Facilitate Sleep.
The Medical clinics of North America·2026
Sleep Disorder Management: Cardiovascular, Endocrine Disorders and Other Special Populations.
The Medical clinics of North America·2026
Diagnostic Tools in Sleep Medicine.
The Medical clinics of North America·2026
Sudden Death Sleeping: Ways, Whys and Enigmas.
The Medical clinics of North America·2026
Sleep and Substance Use Disorders: A Primer for the Clinician.
The Medical clinics of North America·2026
Construction and application of a medication adherence management program based on TIR for patients with ischemic stroke.
Frontiers in public health·2026
Effect of different acupuncture modalities on sex hormone levels in perimenopausal women: a network meta-analysis.
Frontiers in endocrinology·2026
Special, Sensitive, and Difficult-to-Treat Areas: Clarifying the Terminology in Atopic Dermatitis.
International journal of dermatology·2026
A comprehensive assessment of cholinesterase inhibitors for the treatment of Alzheimer's disease based on drug selection recommendations for Chinese Medical Institutions.
Expert review of pharmacoeconomics & outcomes research·2026